TGFB1 and neoplasm: The immune-evasion phenotype is generally characterised by the activation of mesenchymal signalling pathways, such as high TGF-β expression, myeloid inflammation and tumour neovascularisation (Fukumura et al., 2018; Metelli et al., 2018; Hegde and Chen, 2020).